M. Amneus

1.1k total citations
18 papers, 854 citations indexed

About

M. Amneus is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, M. Amneus has authored 18 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 7 papers in Reproductive Medicine and 4 papers in Oncology. Recurrent topics in M. Amneus's work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer, Lipids, and Metabolism (3 papers). M. Amneus is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer, Lipids, and Metabolism (3 papers). M. Amneus collaborates with scholars based in United States and Hungary. M. Amneus's co-authors include Srinivasa T. Reddy, Robin Farias‐Eisner, Feng Su, Jennifer M. Lang, Vladimir Nossov, Jo Marie Tran Janco, Katherine R. Kozak, Víctor Grijalva, G.M. Anantharamaiah and Mohamad Navab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

M. Amneus

18 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Amneus United States	10	354	273	245	169	139	18	854
Jason D. Thorpe United States	16	201 0.6×	431 1.6×	170 0.7×	59 0.3×	162 1.2×	22	794
L. Daly United States	13	236 0.7×	418 1.5×	118 0.5×	52 0.3×	177 1.3×	20	746
Karen Sibley United Kingdom	8	176 0.5×	606 2.2×	137 0.6×	70 0.4×	126 0.9×	10	824
Eliane T. Taube Germany	15	175 0.5×	316 1.2×	70 0.3×	56 0.3×	165 1.2×	53	637
S. Goodrich United States	9	180 0.5×	511 1.9×	161 0.7×	29 0.2×	142 1.0×	14	737
Mu‐Hsien Yu Taiwan	21	813 2.3×	255 0.9×	323 1.3×	28 0.2×	236 1.7×	43	1.4k
Chiao‐Yun Lin Taiwan	18	410 1.2×	124 0.5×	146 0.6×	30 0.2×	151 1.1×	71	822
Lyndal Anderson Australia	14	217 0.6×	185 0.7×	105 0.4×	30 0.2×	170 1.2×	51	768
Iwona Podzielinski United States	10	164 0.5×	492 1.8×	165 0.7×	28 0.2×	148 1.1×	18	768
J. M. G. Bonfrer Netherlands	14	255 0.7×	186 0.7×	90 0.4×	27 0.2×	202 1.5×	25	670

Countries citing papers authored by M. Amneus

Since Specialization

Citations

This map shows the geographic impact of M. Amneus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Amneus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Amneus more than expected).

Fields of papers citing papers by M. Amneus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Amneus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Amneus. The network helps show where M. Amneus may publish in the future.

Co-authorship network of co-authors of M. Amneus

This figure shows the co-authorship network connecting the top 25 collaborators of M. Amneus. A scholar is included among the top collaborators of M. Amneus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Amneus. M. Amneus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Amneus, M., et al.. (2022). Clinical use of PARP inhibitor in recurrent uterine leiomyosarcoma with presence of a somatic BRCA2 mutation. Gynecologic Oncology Reports. 42. 101044–101044. 10 indexed citations

Neal, Adam, Tiffany Lai, Anela Tosevska, et al.. (2020). Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia. Reproductive Sciences. 27(9). 1778–1790. 7 indexed citations

Dessources, Kimberly, et al.. (2020). Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization. Cancer. 126(23). 5060–5068. 9 indexed citations

Holschneider, Christine H., et al.. (2018). An analysis of factors contributing to patients failing to receive brachytherapy as part of primary chemoradiation for locoregional cervical cancer. Gynecologic Oncology. 149(3). 625–626. 1 indexed citations

Zakhour, Mae, Arthur C. Gibson, Chisa Aoyama, et al.. (2017). Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well‐differentiated endometrial adenocarcinoma: a consecutive case series. BJOG An International Journal of Obstetrics & Gynaecology. 124(10). 1576–1583. 50 indexed citations

Dessources, Kimberly, et al.. (2017). The cost-effectiveness of cancer care navigation in patients with locoregional cervical cancer undergoing primary chemoradiation. Gynecologic Oncology. 145. 71–71. 3 indexed citations

Beavis, Anna, et al.. (2015). Almost half of women with endometrial cancer or hyperplasia do not know that obesity affects their cancer risk. SHILAP Revista de lepidopterología. 13. 71–75. 20 indexed citations

Maggard‐Gibbons, Melinda, et al.. (2014). Cervical cancer treatment and survivorship needs: The patient's perspective. Gynecologic Oncology. 133. 51–52. 1 indexed citations

Amneus, M., et al.. (2014). Improving quality of care with cervical cancer patient navigation. Gynecologic Oncology. 133. 34–34. 2 indexed citations

10.

Amneus, M., et al.. (2013). Routine bilateral salpingectomy at the time of hysterectomy with ovarian preservation. Gynecologic Oncology. 130(1). e95–e96. 1 indexed citations

11.

Beavis, Anna, M. Amneus, Chisa Aoyama, & Christine H. Holschneider. (2012). Tattoo Pigment Lymphadenopathy Mimicking Metastasis in Vulvar Cancer. Obstetrics and Gynecology. 120(Part 2). 442–444. 9 indexed citations

12.

Su, Feng, Satoshi Imaizumi, Feng Gao, et al.. (2010). Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proceedings of the National Academy of Sciences. 107(46). 19997–20002. 170 indexed citations

13.

Ioffe, Yevgeniya, M. Amneus, Beth Y. Karlan, et al.. (2010). Before and after GOG 99: Did our practice patterns for treatment of intermediate risk endometrial adenocarcinoma change?. Gynecologic Oncology. 116(3). 595–595. 2 indexed citations

14.

Nosov, Vladimir, Feng Su, M. Amneus, et al.. (2009). Validation of serum biomarkers for detection of early-stage ovarian cancer. American Journal of Obstetrics and Gynecology. 200(6). 639.e1–639.e5. 88 indexed citations

15.

Nossov, Vladimir, M. Amneus, Feng Su, et al.. (2008). The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?. American Journal of Obstetrics and Gynecology. 199(3). 215–223. 231 indexed citations

16.

Amneus, M. & Sathima Natarajan. (2003). Pathologic quiz case: a rare tumor of the ovary.. Archives of Pathology & Laboratory Medicine. 127(7). 890–2. 11 indexed citations

17.

Kozak, Katherine R., et al.. (2003). Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proceedings of the National Academy of Sciences. 100(21). 12343–12348. 231 indexed citations

18.

Amneus, M. & Sathima Natarajan. (2003). Pathologic Quiz Case: A Rare Tumor of the Ovary. Archives of Pathology & Laboratory Medicine. 127(7). 890–892. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact